NCT02061787 the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
| NCT ID | NCT02061787 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese Pulmonary Vascular Disease Research Group |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2010-09 |
| Primary Completion | 2030-09-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2010-09 with a primary completion date of 2030-09-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
Eligibility Criteria
Inclusion Criteria: * pulmonary arterial hypertension;( WHO1) * chronic thromboembolic pulmonary hypertension; * pulmonary arterial hypertension due to other cause; Exclusion Criteria: * massive hemoptysis; * unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders; * recent recurrent syncope; * pulmonary hypertension due to hypoxia; * pulmonary hypertension due to left heart diseases.
Contact & Investigator
Zhihong Liu, MD，PhD
STUDY DIRECTOR
Fuwai Hospital, National Center for Cardiovascular Diseases
Frequently Asked Questions
Who can join the NCT02061787 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 100 Years, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02061787 currently recruiting?
Yes, NCT02061787 is actively recruiting participants. Contact the research team at zhihongliufuwai@163.com for enrollment information.
Where is the NCT02061787 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT02061787 clinical trial?
NCT02061787 is sponsored by Chinese Pulmonary Vascular Disease Research Group. The principal investigator is Zhihong Liu, MD，PhD at Fuwai Hospital, National Center for Cardiovascular Diseases. The trial plans to enroll 4,000 participants.